Vanguard Group Inc Avidity Biosciences, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,248,302 shares of RNA stock, worth $409 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,248,302
Previous 9,243,205 0.06%
Holding current value
$409 Million
Previous $273 Million 3.74%
% of portfolio
0.0%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$24.08 - $36.24 $122,735 - $184,715
5,097 Added 0.06%
9,248,302 $263 Million
Q1 2025

May 09, 2025
SELL
$27.05 - $35.11 $5.1 Million - $6.63 Million
-188,706 Reduced 2.0%
9,243,205 $273 Million
Q4 2024

Feb 11, 2025
BUY
$29.08 - $52.5 $5.96 Million - $10.8 Million
205,027 Added 2.22%
9,431,911 $274 Million
Q3 2024

Nov 13, 2024
BUY
$37.21 - $48.14 $122 Million - $158 Million
3,283,202 Added 55.24%
9,226,884 $424 Million
Q2 2024

Aug 13, 2024
BUY
$22.73 - $40.85 $47.7 Million - $85.7 Million
2,098,610 Added 54.58%
5,943,682 $243 Million
Q1 2024

May 10, 2024
SELL
$9.16 - $25.52 $1.81 Million - $5.06 Million
-198,107 Reduced 4.9%
3,845,072 $98.1 Million
Q4 2023

Feb 14, 2024
BUY
$4.87 - $9.37 $139,715 - $268,815
28,689 Added 0.71%
4,043,179 $36.6 Million
Q3 2023

Nov 14, 2023
BUY
$6.3 - $11.35 $298,021 - $536,911
47,305 Added 1.19%
4,014,490 $25.6 Million
Q2 2023

Aug 14, 2023
BUY
$10.62 - $17.34 $5.16 Million - $8.42 Million
485,468 Added 13.94%
3,967,185 $44 Million
Q1 2023

May 15, 2023
BUY
$15.35 - $25.65 $170,246 - $284,484
11,091 Added 0.32%
3,481,717 $53.4 Million
Q4 2022

Feb 10, 2023
BUY
$10.06 - $22.66 $7.77 Million - $17.5 Million
772,250 Added 28.62%
3,470,626 $77 Million
Q3 2022

Nov 14, 2022
BUY
$15.46 - $23.43 $4.27 Million - $6.47 Million
276,254 Added 11.41%
2,698,376 $44.1 Million
Q2 2022

Aug 12, 2022
BUY
$11.18 - $20.5 $1.38 Million - $2.54 Million
123,759 Added 5.38%
2,422,122 $35.2 Million
Q1 2022

May 13, 2022
BUY
$14.2 - $23.78 $4.19 Million - $7.01 Million
294,791 Added 14.71%
2,298,363 $42.5 Million
Q4 2021

Feb 14, 2022
BUY
$20.4 - $28.66 $1.24 Million - $1.75 Million
60,959 Added 3.14%
2,003,572 $47.6 Million
Q3 2021

Nov 12, 2021
BUY
$18.16 - $25.21 $12.2 Million - $16.9 Million
670,815 Added 52.75%
1,942,613 $47.8 Million
Q2 2021

Aug 13, 2021
BUY
$19.62 - $29.26 $25 Million - $37.2 Million
1,271,798 New
1,271,798 $31.4 Million

Others Institutions Holding RNA

# of Institutions
232
Shares Held
119M
Call Options Held
340K
Put Options Held
145K
View Full List

About Avidity Biosciences, Inc.

RNA Quotes by TradingView
  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.3B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email